Other Countries Archive

17 September 2026

Regarding the Provision of Information for the Proper Use of Over-the-Counter Drugs and Other Medicinal Products, and the Implementation of Adverse Reaction Reporting for Suspected Cases of Dependence (Request for Dissemination)

23 July 2026

Regulatory Guidance on GCP compliance inspection framework – Singapore (2026)

9 July 2026

Notification of the Procedures for Submission of Applications and GDP Inspection for the Year 2026 – Thailand (2025)

1 June 2026

Singapore and Japan Strenghten Regulatory Cooperation in Health Products

25 May 2026

Policy on the Handling of Pharmaceutical Patents in Relation to the Approval Review under the Pharmaceuticals and Medical Devices Act and the National Health Insurance Price Listing of Medical-use Generic Drugs and Biosimilars – Japan (2025)

2 May 2026

Regulations Regarding Clinical Drug – Vietnam (2025)

20 April 2026

Singapore’s HSA Starts Accepting eCTD Packages for Regulatory Dossier Applications

30 March 2026

Comprehensive Lifecycle Collaboration Plan for the Promotion of Pharmaceutical and Biotechnology Ventures – South Korea (2026)

23 January 2026

Circular on Prescribing Marketing Authorization of Drugs and Medicinal Materials – Vietnam (2025)

12 November 2025

Early Consideration on Handling of Japanese Data for Confirmation of Comparability of Biosimilars to the Original Biopharmaceuticals (2025)